Advarra, the market leader in regulatory reviews and a leading provider of clinical research technology, today announced the ...

AT278 combines two fundamental properties, ultra-high concentration and an ultra-rapid profile, which provide the potential ...

PhaseV, a leader in AI/ML for clinical development, today announced a strategic partnership with Bioforum, a leading Contract ...

SPEAR proposal reflects current evidence on monoclonal antibodies in treatment for Long COVID and identifies VYD2311 as a promising ...

Adaptive clinical trial design represents a modern approach to evaluating healthcare interventions that allows pre‐specified modifications based on accumulating data. This flexible methodology ...

Clinical trial participants now expect clinical tools to match the usability of the digital tools they use every day.

About TransCelerate BioPharma Inc. TransCelerate BioPharma (TransCelerate) is a nonprofit organization that fosters collaboration across the global biopharmaceutical research and development community ...

Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on the development of inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced a poster ...

HAS COMMENCED RECRUITMENT IN THIS 36 PARTICIPANT STUDY PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / / Medicus Pharma Ltd. ...

"We are excited to see Pfizer advancing MesoC2 into clinical development rapidly, highlighting the potential of Nona's Harbour Mice® and integrated ADC platforms to deliver innovative cancer therapies ...